Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Loss-of-function genetic screens as a tool to improve the diagnosis and treatment of cancer
Oncogene, 09/24/09
Mullenders J et al. – A major impediment to the effective treatment of cancer is the molecular heterogeneity of the disease, which is also reflected in an equally diverse pattern of clinical responses to therapy. In this study, the authors discuss how RNA interference–based genetic screens can be used to address these two pressing needs in the care for cancer patients.
Related Articles
Gene expression markers for genetic risk groups and survival in chronic lymphocytic leukemia
Haematologica, 12/03/09
Relevance Score: 67%
Role of Second-Trimester Genetic Sonography After Down Syndrome Screening
Obstetrics and Gynecology, 12/01/09
Relevance Score: 67%
Assessing the usefulness of a novel MRI-based breast density estimation algorithm in a cohort of women at high genetic risk of breast cancer: The UK MARIBS study
Breast Cancer Research, 11/17/09
Relevance Score: 67%
Screening for clonal hematopoiesis as a predictive marker for development of therapy-related myeloid neoplasia (t-MN) following neoadjuvant therapy for breast cancer: a Southwest Oncology Group study (S0012)
Breast Cancer Research and Treatment, 11/04/09
Relevance Score: 66%
Genetic association between AZF region polymorphism and Klinefelter syndrome
Reproductive BioMedicine Online, 11/24/09
Relevance Score: 65%
Today in Diagnostics/Radiology...keeping you current
Receive free subspecialty "5-minute updates" via email
Immunoprofile of mesenchymal chondrosarcoma: aberrant desmin and EMA expression, retention of INI1, and negative estrogen receptor in 22 female-predominant central nervous system and musculoskeletal cases
Annals of Diagnostic Pathology, 12/11/09
Reporting of prognostic studies of tumour markers: a review of published articles in relation to REMARK guidelines
British Journal of Cancer, 12/11/09
Diagnosis of platelet-type von Willebrand disease by flow cytometry
Haematologica, 12/09/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


